Jacob N. Peterson

Jacob N. Peterson

Auto-generated profile, based on publicly available information

Jacob N. Peterson

Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SGSarah A. Greaves
Sarah A. Greaves
JPJacob N. Peterson
Jacob N. Peterson
PSPamela Strauch
Pamela Strauch
RTRaul M. Torres
Raul M. Torres
RPRoberta Pelanda
Roberta Pelanda
Autoreactive B cells that bind self-antigen with high avidity in the bone marrow undergo mechanisms of central tolerance that prevent their entry into the peripheral B cell population. These mechanisms are breached in many autoimmune patients, increasing their risk of B cell–mediated autoimmune diseases. Resolving the molecular pathways that can break central B cell tolerance could therefore provide avenues to diminish autoimmunity. Here, we show that B cell–intrinsic expression of a constitutively active form of PI3K-P110α by high-avidity autoreactive B cells of mice completely abrogates central B cell tolerance and further promotes these cells to escape from the bone marrow, differentiate in peripheral tissue, and undergo activation in response to self-antigen. Upon stimulation with T cell help factors, these B cells secrete antibodies in vitro but remain unable to secrete autoantibodies in vivo. Overall, our data demonstrate that activation of the PI3K pathway leads high-avidity autoreactive B cells to breach central, but not late, stages of peripheral tolerance.

20 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TCThiago Alves da Costa
Thiago Alves da Costa
JPJacob N. Peterson
Jacob N. Peterson
JLJulie Lang
Julie Lang
JSJeremy Shulman
Jeremy Shulman
XLXiayuan Liang
Xiayuan Liang
RPRoberta Pelanda
Roberta Pelanda
Central B cell tolerance, the process restricting the development of many newly generated autoreactive B cells, has been intensely investigated in mouse cells while studies in humans have been hampered by the inability to phenotypically distinguish autoreactive and nonautoreactive immature B cell clones and the difficulty in accessing fresh human bone marrow samples. Using a human immune system mouse model in which all human Igκ+ B cells undergo central tolerance, we discovered that human autoreactive immature B cells exhibit a distinctive phenotype that includes lower activation of ERK and differential expression of CD69, CD81, CXCR4, and other glycoproteins. Human B cells exhibiting these characteristics were observed in fresh human bone marrow tissue biopsy specimens, although differences in marker expression were smaller than in the humanized mouse model. Furthermore, the expression of these markers was slightly altered in autoreactive B cells of humanized mice engrafted with some human immune systems genetically predisposed to autoimmunity. Finally, by treating mice and human immune system mice with a pharmacologic antagonist, we show that signaling by CXCR4 is necessary to prevent both human and mouse autoreactive B cell clones from egressing the bone marrow, indicating that CXCR4 functionally contributes to central B cell tolerance. Significance A better understanding of how central B cell tolerance operates in human B cells can lead to developing approaches that reduce bone marrow egress of autoreactive B cell clones and their burden in circulation. Using a human immune system mouse model, this study characterizes the phenotype of human autoreactive immature B cells undergoing central tolerance and shows that cells with a similar but more subtle phenotype are present within fresh human bone marrow tissue. Treatment of mice with a pharmacologic antagonist of CXCR4, one of the markers of central B cell tolerance, demonstrates CXCR4 is necessary to prevent autoreactive human and mouse B cell clones from egressing the bone marrow, thus contributing to the establishment of tolerance.